VarmX and Rentschler Biopharma partner to advance novel coagulation therapy toward Phase 3 and commercialization

VarmX and Rentschler Biopharma expand collaboration from early development to late ‑ stage and commercial manufacturing of VMX-C001 VMX ‑ C001 ...
Taiwan News

Atea Pharmaceuticals to Highlight 2026 Strategic Priorities at the 44th Annual J.P. Morgan Healthcare Conference

Atea continues to advance its global Phase 3 program evaluating the fixed-dose combination (FDC) of BEM, a nucleotide analog HCV NS5B polymerase inhibitor, and RZR, an HCV NS5A inhibitor, for the ...
Scientific Research PublishingOpinion

A Reflection on the Modernity of Bottled Water ()

The industrial and commercial expansion of bottled water hinges on advancements in purification technology. As the pivotal ...

EnviroGold Delivers Strong 2025 Execution and Establishes a Clear Path to Commercial Growth in 2026

EnviroGold Global Limited (CSE: NVRO \| OTCQB: ESGLF \| FSE: YGK) (“EnviroGold” or the “Company”) reported a y ...

Silex Systems: Government Support Now In Question

Silex Systems' failure to receive large amounts of funding from the most recent DOE awards disappointed investors. Read why ...
The Globe and Mail

EnviroGold Global Appoints PPM Global, Completes NVRO Process™ Optimization and Launches Mobile Pilot Plant to Accelerate NVRO Process™ Commercialization

VANCOUVER, British Columbia, Dec. 01, 2025 (GLOBE NEWSWIRE) -- EnviroGold Global Limited (CSE: NVRO | OTCQB: ESGLF | FSE: YGK) (“EnviroGold” or the “Company”), is pleased to announce advancements ...
FOX59 News

EnviroGold Global Strengthens Leadership Team with Appointment of Chief Technology Officer and Project Manager to Drive NVRO Process™ Commercialization

EnviroGold has appointed Arthur Gooch, P.Eng., as Chief Technology Officer, effective immediately. Arthur brings more than 20 years of global experience in process plant digital modelling and ...